ArtiQ
- hard tech
- biotechnology
- horizon europe
- core ai
- testing
- spinout
- ai applications
- eit ecosystem
- eit health
- techbio
- tech for hospitals & clinics
- health it
- tech for medical professionals
- physician support tools
- health diagnostics
- ai drug discovery
- techbio drug discovery
- clinical decision support
- headstart (eit health)
- ai agents
- medical imaging
- ai for imaging
- mentoring and coaching network (eit health)
- respiratory
- headstart 2019 (eit health)
- mentoring and coaching network 2020 (eit health)
- pulmonary
- lungs
- start-ups meet pharma (eit health)
- start-ups meet pharma 2020 (eit health)
Financials
Estimates*
EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EBITDA | (<1m) | (<1m) | <1m | <1m | - |
Profit | (<1m) | (<1m) | (<1m) | <1m | <1m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | Seed | ||
| $1.1m | Seed | |
€50.0k | Grant | ||
€10.0k | Grant | ||
€1.5k | Grant | ||
* | N/A | Acquisition | |
Total Funding | CAD1.6m |
Related Content
Recent News about ArtiQ
EditArtiQ is a startup that operates in the healthcare technology sector, specifically focusing on pulmonary function. The company has developed software solutions that utilize artificial intelligence (AI) to improve the interpretation of Pulmonary Function Tests (PFTs) and automate the assessment of spirometry quality. Spirometry is a common test used to assess how well your lungs work by measuring how much air you inhale, how much you exhale and how quickly you exhale.
ArtiQ's software solutions, ArtiQ.PFT and ArtiQ.QC, serve a wide range of clients, including pulmonologists, respiratory researchers, and epidemiologists. The software is designed to provide a more accurate and efficient interpretation of PFTs, which can lead to better patient outcomes and more successful clinical trials.
The company's business model revolves around selling these software solutions to healthcare providers and research institutions. By automating and improving the interpretation of PFTs, ArtiQ's software can save time for healthcare professionals and increase the reliability of respiratory research.
ArtiQ's software solutions have been thoroughly tested and validated, with their findings published in key scientific journals and presented at international scientific and medical conferences. The company is ISO 13585 certified, and its ArtiQ.PFT solution is CE marked, indicating it meets high safety, health, and environmental protection requirements.
Keywords: Healthcare Technology, Pulmonary Function, Artificial Intelligence, Spirometry, Software Solutions, Pulmonologists, Respiratory Research, Clinical Trials, ISO 13585 Certified, CE Marked.